To more comprehensively characterize genetic events underlying PRAME downmodulation, we next investigated associations of somatic genetic alterations with PRAME protein expression (IHC positive: 30%, IHC negative: 70%) in our DLBCL cohort. This evidence concerns the gene PRAME and diffuse large B-cell lymphoma.